SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:b2878c4b-49eb-45b5-9d29-dcce21d61a17"
 

Search: onr:"swepub:oai:lup.lub.lu.se:b2878c4b-49eb-45b5-9d29-dcce21d61a17" > A multicentre, rand...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission.

Chatzidionysiou, Katerina (author)
Karolinska Institutet
Turesson, Carl (author)
Lund University,Lunds universitet,Internmedicin - epidemiologi,Forskargrupper vid Lunds universitet,Internal Medicine - Epidemiology,Lund University Research Groups,Lund Univ, Dept Clin Sci, Rheumatol, Malmo, Sweden
Teleman, Annika (author)
Capio Movement, Reumatol, Halmstad, Sweden
show more...
Knight, Ann (author)
Uppsala universitet,Reumatologi
Lindqvist, Elisabet (author)
Lund University,Lunds universitet,Reumatologi och molekylär skelettbiologi,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Rheumatology,Section III,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Rheumatol, Lund, Sweden
Larsson, Per (author)
Karolinska Institutet
Cöster, Lars (author)
Univ Hosp, Dept Rheumatol, Linkoping, Sweden
Forslind, Kristina (author)
Lund University,Lunds universitet,Kliniska Vetenskaper, Helsingborg,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Clinical Sciences, Helsingborg,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Helsingborg Hosp, Rheumatol Sect, Dept Med, Helsingborg, Sweden;Lund Univ, Dept Clin Sci, Rheumatol, Helsingborg, Sweden
van Vollenhoven, Ronald (author)
Karolinska Institutet
Heimbürger, Mikael (author)
AbbVie AB, Stockholm, Sweden
show less...
 (creator_code:org_t)
2016-01-14
2016
English.
In: RMD Open. - : BMJ. - 2056-5933. ; 2:1, s. 000133-000133
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Treatment with tumour necrosis factor (TNF) blockers, once started as therapy for rheumatoid arthritis (RA), is usually continued indefinitely. The aim of this trial was to assess the possibility of discontinuing treatment with adalimumab (ADA) while maintaining remission in patients with RA with established disease in stable remission on combination therapy with ADA and methotrexate (MTX).

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Reumatologi och inflammation (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Rheumatology and Autoimmunity (hsv//eng)

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

  • RMD Open (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view